Pharmaceutical Technology

JUNE 25, 2025

The first tranche will be received by Revolution, following US Food and Drug Administration (FDA) approval of daraxonrasib to treat metastatic PDAC by January 2028. The debt facility portion consists of three tranches totalling up to $750m linked directly to daraxonrasib’s commercial milestones. Sign up for our daily news round-up!

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 10, 2025

Keytruda, which brought in $30bn in revenue in 2024, is approaching patent expirations set in 2028, and Merck is therefore intensifying efforts to restructure its portfolio, according to a report by Reuters. This agreement will enable the strong launch trajectory of this important medicine and provides value to Verona Pharma shareholders.”

Packaging 52

Packaging Hospitals Communication FDA 52

Pharmaceutical Technology

JUNE 10, 2025

Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028, RFK Jr wrote. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

Vaccines 52

Vaccines FDA Immunization Communication 52

The Checkup by Singlecare

DECEMBER 12, 2024

Without insurance, Addyi costs $1055 for 30, 100mg tablets. Addyi is currently only available as a brand-name drug , but a generic Addyi may be available after 2028. Is Addyi covered by insurance? You can contact your insurance provider directly to learn more about coverage and associated costs. Addyi is no exception.

Insurance 52

Insurance Insurance Coverage Documentation FDA 52